Nanopharmaceuticals Market to Surpass US$ 168.9 Billion by 2026 : Abbott, GlaxoSmithKline Plc., Eli Lilly and Company, Astrazeneca Plc., Novavax, Inc., Stryker Corporatio
Nanopharmaceuticals play a major role in advance healthcare, as it is widely used in drug delivery. Nanopharmaceuticals differ from other macroscopic level of medicines in its shape and composition and offer advantages over the bulk analogues such as precision targeting and patient compliance.
View full press release